NASDAQ : SNTI
Senti Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.217 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.76M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Senti Biosciences, Inc. (SNTI) reported revenue of 55.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 55.00K | 22.00K | 2.56M | 4.29M | 2.76M | |
| Cost of Revenue | 31.32M | 37.59M | 34.36M | 32.15M | 28.14M | 21.96M |
| Gross Profit | -31.27M | -37.56M | -34.36M | -29.59M | -23.86M | -19.20M |
| Selling, General & Admin | 22.05M | 20.74M | 19.92M | 34.85M | 38.23M | 21.25M |
| Operating Expenses | 22.05M | 20.74M | 19.92M | 34.85M | 38.23M | 21.25M |
| Operating Income | -53.32M | -58.30M | -54.28M | -64.44M | -62.08M | -40.45M |
| Interest & Investment Income | 419.00K | 927.00K | 948.00K | 2.86M | 1.70M | 11.00K |
| Other Non Operating Income (Expenses) | 1.51M | 991.00K | 18.07M | 3.30M | -32.00K | -120.00K |
| EBT Excluding Unusual Items | -51.39M | -56.39M | -35.26M | -58.28M | -60.41M | -40.55M |
| Asset Writedown | -5.05M | -5.05M | -313.00K | -25.96M | -22.00K | |
| Other Unusual Items | 6.88M | -17.22M | 833.00K | 10.75M | -14.74M | |
| Pretax Income | -49.56M | -61.44M | -52.79M | -83.41M | -49.66M | -55.32M |
| Earnings From Continuing Operations | -49.56M | -61.44M | -52.79M | -83.41M | -49.66M | -55.32M |
| Earnings From Discontinued Operations | 12.35M | -8.54M | ||||
| Net Income | -49.56M | -61.44M | -52.79M | -71.06M | -58.21M | -55.32M |
| Preferred Dividends & Other Adjustments | 2.52M | |||||
| Net Income to Common | -49.56M | -61.44M | -55.31M | -71.06M | -58.21M | -55.32M |
| Shares Outstanding (Basic) | 28.97M | 22.48M | 4.60M | 4.44M | 2.61M | 291.23K |
| Shares Outstanding (Diluted) | 28.97M | 22.48M | 4.60M | 4.44M | 2.61M | 291.23K |
| EPS (Basic) | -1.71 | -2.73 | -12.03 | -16.01 | -22.29 | -189.95 |
| EPS (Diluted) | -1.71 | -2.73 | -12.03 | -16.01 | -22.29 | -189.95 |
| Free Cash Flow | -38.05M | -43.64M | -41.42M | -64.43M | -76.27M | -40.18M |
| Free Cash Flow Per Share | -1.31 | -1.94 | -9.01 | -14.52 | -29.21 | -137.96 |
| Operating Margin | -96,943.64% | -265,018.18% | -2,516.28% | -1,448.53% | -1,464.90% | |
| Profit Margin | -90,116.36% | -279,263.64% | -2,774.62% | -1,358.14% | -2,003.59% | |
| Free Cash Flow Margin | -69,183.64% | -198,363.64% | -2,515.93% | -1,779.51% | -1,455.20% | |
| EBITDA | -50.17M | -54.67M | -50.44M | -60.88M | -60.69M | -39.68M |
| D&A For EBITDA | 3.15M | 3.64M | 3.84M | 3.56M | 1.40M | 769.00K |
| EBIT | -53.32M | -58.30M | -54.28M | -64.44M | -62.08M | -40.45M |
| Revenue as Reported | 2.56M | 4.29M | 2.76M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 6.46M | 16.42M | 48.28M | 35.93M | 57.62M | 56.03M |
| Short-Term Investments | 144.00K | 315.00K | 335.00K | 42.00K | 42.15M | 1.16M |
| Cash & Short-Term Investments | 6.61M | 16.73M | 48.61M | 35.97M | 99.77M | 57.19M |
| Accounts Receivable | 323.00K | 112.00K | 626.00K | 483.00K | ||
| Other Receivables | 557.00K | 1.27M | 1.80M | 17.59M | ||
| Receivables | 557.00K | 1.59M | 1.80M | 17.70M | 626.00K | 483.00K |
| Prepaid Expenses | 5.55M | 4.94M | 7.96M | 17.33M | 1.87M | 798.00K |
| Other Current Assets | 288.00K | 584.00K | 195.00K | 310.00K | 1.72M | |
| Total Current Assets | 13.01M | 23.27M | 58.96M | 71.20M | 102.58M | 60.19M |
| Property, Plant & Equipment | 18.67M | 24.40M | 35.24M | 41.61M | 69.78M | 33.08M |
| Other Long-Term Assets | 1.43M | 3.55M | 3.64M | 6.67M | 8.43M | 3.43M |
| Total Assets | 33.10M | 51.22M | 97.84M | 119.48M | 180.79M | 96.70M |
| Accounts Payable | 2.25M | 2.94M | 1.45M | 1.25M | 1.37M | 5.19M |
| Accrued Expenses | 3.57M | 5.28M | 5.95M | 5.93M | 12.58M | 5.33M |
| Current Portion of Leases | 3.49M | 5.33M | 4.65M | 4.13M | 1.99M | 1.74M |
| Current Unearned Revenue | 1.95M | 347.00K | 660.00K | 989.00K | 799.00K | 1.66M |
| Other Current Liabilities | 508.00K | 73.00K | 433.00K | 378.00K | 1.32M | 626.00K |
| Total Current Liabilities | 15.77M | 13.97M | 13.15M | 12.67M | 18.05M | 14.54M |
| Long-Term Leases | 12.74M | 23.56M | 28.89M | 33.54M | 35.10M | 20.99M |
| Long-Term Unearned Revenue | 8.00M | 7.95M | 4.90M | 176.00K | ||
| Other Long-Term Liabilities | 149.00K | 149.00K | 6.36M | 373.00K | 619.00K | |
| Total Liabilities | 36.51M | 45.63M | 47.09M | 52.57M | 53.53M | 36.33M |
| Common Stock | 3.00K | 3.00K | 1.00K | 1.00K | 4.00K | |
| Additional Paid-In Capital | 372.14M | 364.16M | 322.78M | 311.26M | 300.54M | 3.62M |
| Retained Earnings | -375.54M | -358.57M | -297.13M | -244.34M | -173.29M | -115.08M |
| Comprehensive Income & Other | 1.00K | |||||
| Total Common Equity | -3.40M | 5.59M | 25.65M | 66.91M | 127.26M | -111.46M |
| Shareholders' Equity | -3.40M | 5.59M | 50.76M | 66.91M | 127.26M | 60.38M |
| Total Liabilities & Equity | 33.10M | 51.22M | 97.84M | 119.48M | 180.79M | 96.70M |
| Total Debt | 20.23M | 28.89M | 33.54M | 37.67M | 37.09M | 22.73M |
| Net Cash (Debt) | -13.62M | -12.16M | 15.07M | -1.70M | 62.68M | 34.46M |
| Net Cash Per Share | -0.47 | -0.54 | 3.28 | -0.38 | 24.01 | 118.33 |
| Filing Date Shares Outstanding | 31.14M | 31.14M | 26.00M | 4.57M | 4.42M | 1.52M |
| Total Common Shares Outstanding | 31.14M | 30.88M | 4.83M | 4.57M | 4.41M | 1.52M |
| Working Capital | -2.76M | 9.30M | 45.81M | 58.53M | 84.53M | 45.65M |
| Book Value Per Share | -0.11 | 0.18 | 5.31 | 14.64 | 28.88 | -73.38 |
| Tangible Book Value | -3.40M | 5.59M | 25.65M | 66.91M | 127.26M | -111.46M |
| Tangible Book Value Per Share | -0.11 | 0.18 | 5.31 | 14.64 | 28.88 | -73.38 |
| Machinery | 7.93M | 8.20M | 8.18M | 8.87M | 8.55M | 5.54M |
| Construction In Progress | 43.89M | 8.05M | ||||
| Leasehold Improvements | 17.75M | 17.75M | 22.66M | 22.65M | 1.87M | 431.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -49.56M | -61.44M | -52.79M | -71.06M | -58.21M | -55.32M |
| Depreciation & Amortization | 3.15M | 3.64M | 3.84M | 5.43M | 3.92M | 3.01M |
| Loss (Gain) From Sale of Assets | -21.86M | |||||
| Asset Writedown & Restructuring Costs | 5.05M | 5.05M | 313.00K | 25.96M | 22.00K | |
| Loss (Gain) From Sale of Investments | -1.07M | -356.00K | ||||
| Stock-Based Compensation | 5.34M | 5.71M | 1.75M | 9.67M | 16.39M | 2.29M |
| Other Operating Activities | -6.68M | 39.00K | -584.00K | -4.13M | -10.55M | 14.74M |
| Change in Accounts Receivable | 3.13M | 210.00K | -712.00K | -929.00K | -131.00K | -395.00K |
| Change in Accounts Payable | 1.25M | 1.74M | 797.00K | -290.00K | 186.00K | -617.00K |
| Change in Unearned Revenue | 1.59M | -313.00K | -329.00K | -110.00K | -1.03M | 1.83M |
| Change in Other Net Operating Assets | -1.33M | 1.92M | 6.32M | 5.99M | 14.88M | -205.00K |
| Operating Cash Flow | -38.05M | -43.44M | -41.40M | -52.40M | -34.90M | -34.63M |
| Capital Expenditures | -196.00K | -26.00K | -12.04M | -41.37M | -5.54M | |
| Sale of Property, Plant & Equipment | 114.00K | 12.00K | 60.00K | 105.00K | ||
| Investment in Securities | 42.01M | -40.59M | ||||
| Investing Cash Flow | 114.00K | -184.00K | 34.00K | 30.08M | -81.96M | -5.54M |
| Long-Term Debt Issued | 117.15M | |||||
| Total Debt Issued | 9.70M | 117.15M | ||||
| Long-Term Debt Repaid | -108.00K | -17.00K | ||||
| Net Debt Issued (Repaid) | 9.70M | -108.00K | 117.15M | -17.00K | ||
| Issuance of Common Stock | 10.65M | 11.18M | 49.06M | 887.00K | 1.40M | 1.50M |
| Other Financing Activities | 493.00K | 581.00K | 4.67M | |||
| Financing Cash Flow | 20.72M | 11.76M | 53.73M | 779.00K | 118.55M | 68.44M |
| Net Cash Flow | -17.22M | -31.87M | 12.37M | -21.54M | 1.70M | 28.26M |
| Free Cash Flow | -38.05M | -43.64M | -41.42M | -64.43M | -76.27M | -40.18M |
| Free Cash Flow Margin | -69,183.64% | -198,363.64% | -2,515.93% | -1,779.51% | -1,455.20% | |
| Free Cash Flow Per Share | -1.31 | -1.94 | -9.01 | -14.52 | -29.21 | -137.96 |
| Levered Free Cash Flow | -17.11M | -23.34M | -3.52M | -75.14M | -57.23M | -17.92M |
| Unlevered Free Cash Flow | -17.11M | -23.34M | -3.52M | -75.14M | -57.23M | -17.92M |
| Change in Working Capital | 4.65M | 3.56M | 6.07M | 4.67M | 13.90M | 615.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.16M | 27.34M | 16.11M | 29.40M | 61.84M | 290.53M |
| Enterprise Value | 18.78M | 44.69M | 39.98M | 26.63M | -20.65M | |
| Last Close Price | 0.17 | 1.04 | 3.51 | 6.60 | 14.10 | 98.60 |
| PS Ratio | 93.49 | 1,242.84 | 11.48 | 14.43 | 105.23 | |
| PB Ratio | 4.89 | 0.32 | 0.44 | 0.49 | 4.81 | |
| P/TBV Ratio | 4.89 | 0.63 | 0.44 | 0.49 | ||
| EV/Sales Ratio | 341.11 | 2,031.25 | 10.40 | |||
| Debt / Equity Ratio | -5.95 | 5.17 | 0.66 | 0.56 | 0.29 | 0.38 |
| Net Debt / Equity Ratio | -4.00 | 2.17 | -0.30 | 0.03 | -0.49 | -0.57 |
| Net Debt / EBITDA Ratio | -0.27 | -0.22 | 0.30 | -0.03 | 1.03 | 0.87 |
| Net Debt / FCF Ratio | -0.36 | -0.28 | 0.36 | -0.03 | 0.82 | 0.86 |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.03 | 0.04 | |
| Quick Ratio | 0.45 | 1.31 | 3.83 | 4.24 | 5.56 | 3.97 |
| Current Ratio | 0.82 | 1.67 | 4.49 | 5.62 | 5.68 | 4.14 |
| Return on Equity (ROE) | -466.46% | -218.08% | -89.73% | -85.91% | -52.94% | -121.15% |
| Return on Assets (ROA) | -65.57% | -48.89% | -31.22% | -26.83% | -27.97% | -34.86% |
| Return on Capital Employed (ROCE) | -307.50% | -156.50% | -64.10% | -60.30% | -38.10% | -49.20% |
| Earnings Yield | -1,033.24% | -224.70% | -327.76% | -241.69% | -94.13% | -19.04% |
| FCF Yield | -740.00% | -159.60% | -257.19% | -219.16% | -123.34% | -13.83% |
| Buyback Yield / Dilution | -155.08% | -389.20% | -3.58% | -69.93% | -796.58% | 78.99% |